Peter Ringrose, PhD
Non-Executive Director
Dr Peter Ringrose served as Chief Scientific Officer of Bristol-Myers Squibb Company and President of the Pharmaceutical Research Institute, where he was responsible for the discovery, preclinical and clinical development of pharmaceutical products worldwide. Previously, he was Senior Vice President and Head of Pfizer Central Research Europe. At Pfizer and BMS Dr. Ringrose was responsible for teams involved in the discovery and development of many significant new medicines. Prior to this he held senior positions at Sandoz Research Institute and Roche.
Dr Ringrose served as Chairman of the UK government’s Biotechnology and Biological Sciences Research Council (2003-2009) and as a Governing Board member of the Technology Strategy Board (2007-2009). He was a Non-Executive Director of Cambridge Antibody Technology and is currently a non-executive director of Astex Therapeutics Ltd and Rigel Pharmaceuticals Inc. He is on the Scientific Advisory Boards of Schering-Plough, Cempra and Accenture. Dr Ringrose is a lifetime Honorary Pitt Fellow of Pembroke College Cambridge, a Council Member of the Foundation for Science and Technology UK and a Member of the New York Academy of Sciences President’s Council.
